Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pear Therapeutics, Inc.

https://peartherapeutics.com/

Latest From Pear Therapeutics, Inc.

Digital Health Roundup, July 2021: Exec Chat With DTA, Start-Ups Grab New Funds, Agency Nods

In this roundup feature focusing on the developments in digital health, we highlight the key news and announcements from July.

Digital Health Artificial Intelligence

Mahana Therapeutics Plans To Use $61M In Series B Financing To Launch IBS Treatment App

Mahana is planning a 2022 nationwide launch of its FDA-cleared prescription digital therapeutic for treating symptoms of irritable bowel syndrome.

Gastrointestinal Digital Health

Exec Chat: New CEO Of Digital Therapeutics Alliance Says Reimbursement Remains Big Issue

In an interview with Medtech Insight, Andy Molnar, new CEO of the Digital Therapeutics Alliance, outlines some of the big issues facing the digital therapeutics industry, which has seen tremendous growth during the pandemic.

Digital Health Reimbursement

Digital Health Roundup, June 2021: Winners In Record-Breaking H1 Digital Health Funding; ADA 2021; Telehealth Update

In this roundup feature focusing on the developments in digital health, we highlight the key news and announcements from June.

Digital Health Telehealth
See All

Company Information

  • Industry
  • Digital Health
  • Medical Devices
  • Pharmaceuticals
UsernamePublicRestriction

Register